
NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Motivational Interviewing to Promote Behavior Change
Best Biomarkers for Inflammation
Atherosclerosis is widely recognized as a chronic inflammatory disorder. Therapies with anti-inflammatory effects in patients with an increased inflammatory status can reduce cardiovascular events, as…
High-sensitivity C-reactive Protein Versus Coronary Artery Calcium Scoring: Dissecting a Biological Target from a Cardiovascular Risk Assessment Tool
Cardiovascular disease (CVD) remains the leading cause of mortality across the globe. The cornerstones of CVD prevention and treatment are accurate risk assessment — such…
A Glimpse at Lipodystrophy – Diagnosis and Treatment
Lipodystrophies are a group of disorders of fat tissue loss that are classified according to whether the condition is genetic or acquired and by the…
Best Practice Guide: PCSK9 Inhibitors
Provided by: National Lipid Association’s Therapeutics Committee Committee Note to Members of the NLAAt the request of the NLA president, the NLA Board of Directors,…
Management of Statin Treatment in Adult Solid Organ Transplant Recipients
Solid organ transplantation (SOT), encompassing kidney, liver, heart and to a lesser extent pancreas and lung, has become routine care for optimal treatment of end-stage…
Lipoprotein X in Graft versus Host Disease of the Liver
This case illustrates a common presentation of a rare phenomenon that should be highlighted so that clinicians are aware of the signs, implications, and management…
Can Coronary Artery Disease Be Prevented? Lessons Learned From Ancient Mummies to the Contemporary Tsimane of the Bolivian Amazon
In 2009, a 75-year-old Tsimane man and his wife awoke and went out into the rain forest around their home in the Amazonian lowlands of…